









|
| @ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹ |
<< Šw‰ïނ֖߂é
<< ‘O‚̃y[ƒW‚Ö–ß‚é
‘æ94‰ñŠwpW‰ïi•½¬9”N10ŒŽ19“új
yˆê”ʉ‰‘èz
Œû‰‰ ”D›s«‰·‘¶‚µ‚½‰ŠúŽq‹{èò•”Malignant Lymphoma‚Ì1—á
Šì”[@“Þ, ’†ì@r‰î, ‰¶“c@‹MŽu, –î–ì@“N, ‹gì@—T”V, •’J@—Y“ñ
“Œ‹ž‘åŠwˆãŠw•”ŽY‰È•wl‰È
“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 34(3)
357-357, 1997
|